Full Press Release Details
Altimmune Announces Submission of Investigational New Drug Application for AdCOVID a Single-dose Intranasal COVID-19 Vaccine; On Track to Commence Phase 1 Clinical Study in December.
ALT
Altimmune Announces Submission of Investigational New Drug Application for AdCOVID a Single-dose Intranasal COVID-19 Vaccine; On Track to Commence Phase 1 Clinical Study in December
Key Takeaway: Altimmune Announces Submission of Investigational New Drug Application for AdCOVID a Single-dose Intranasal COVID-19 Vaccine; On Track to Commence Phase 1 Clinical Study in December